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Abstract
Background:  Counselees are more aware of genetics and seek information, reassurance,
screening and genetic testing. Risk counseling is a key component of genetic counseling process
helping patients to achieve a realistic view for their own personal risk and therefore adapt to the
medical, psychological and familial implications of disease and to encourage the patient to make
informed choices [1,2].
The aim of this study was to conceptualize risk perception and anxiety about cancer in individuals
attending to genetic counseling.
Methods: The questionnaire study measured risk perception and anxiety about cancer at three
time points: before and one week after initial genetic counseling and one year after completed
genetic investigations. Eligibility criteria were designed to include only index patients without a
previous genetic consultation in the family. A total of 215 individuals were included. Data was
collected during three years period.
Results: Before genetic counseling all of the unaffected participants subjectively estimated their
risk as higher than their objective risk. Participants with a similar risk as the population
overestimated their risk most. All risk groups estimated the risk for children's/siblings to be lower
than their own. The benefits of preventive surveillance program were well understood among
unaffected participants.
The difference in subjective risk perception before and directly after genetic counseling was
statistically significantly lower in all risk groups. Difference in risk perception for children as well as
for population was also statistically significant. Experienced anxiety about developing cancer in the
unaffected subjects was lower after genetic counseling compared to baseline in all groups. Anxiety
about cancer had clear correlation to perceived risk of cancer before and one year after genetic
investigations.
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The affected participants overestimated their children's risk as well as risk for anyone in population.
Difference in risk perception for children/siblings as for the general population was significant
between the first and second measurement time points. Anxiety about developing cancer again
among affected participants continued to be high throughout this investigation.
Conclusion:  The participant's accuracy in risk perception was poor, especially in low risk
individuals before genetic counseling. There was a general trend towards more accurate estimation
in all risk groups after genetic counseling. The importance of preventive programs was well
understood. Cancer anxiety was prevalent and associated with risk perception, but decreased after
genetic counseling.
[1] National Society of Genetic Counselors (2005), Genetic Counseling as a Profession. Available
at http://www.nsgc.org/about/definition.cfm (accessed November 25th 2007)
[2] Julian-Reynier C., Welkenhuysen M-, Hagoel L., Decruyenaere M., Hopwood P. (2003) Risk 
communication strategies: state of the art and effectiveness in the context of cancer genetic 
services. Eur J of Human Genetics 11, 725736.
Background
There is increasing public demand for oncogenetic coun-
seling. Today counselees are more aware of genetics and
seek more information, reassurance, screening and
genetic testing. For the oncogenetic clinics, it is challeng-
ing to provide individualized counseling in the way that it
contains all relevant information and fulfill the specific
needs and requests of every patient. Risk information is a
key component of this process. It is intended to help
patients gain realistic views of their personal risk and
adapt that risk to the medical, psychological and familial
implications of cancer. Information about cancer risk
facilitates confidence in making choices about the need of
surveillance interventions and in choosing between differ-
ent control programs and prophylactic procedures. Risk
information can be experienced as severe or harmful, and
therefore needs to be adapted to the patient's ability and
willingness to cope [1,2].
Risk counseling integrates assessments of the: (1) proba-
bility that a genetic susceptibility to cancer exists within
the family, (2) probability that the patient has inherited
predisposing gene(s) and (3) risk that the patient devel-
ops a genetically inherited cancer. These questions con-
cern not only the patient but also close family members
and offspring [2,3]. Risk information is often based on
family history and the probability of inheritance of cancer
ranging from no hereditary cancers to the inevitability of
intervention for survival, although such extremes are rare
[4]. Adequate risk information also includes information
about the condition in question, modifying risk factors,
medical managements and treatment options. The effec-
tiveness of preventive procedures must be addressed along
with information about benefits and limitations related to
testing, practical information of a positive or negative test
result and risk management. Information about available
support groups must also be provided [5].
Hereditary cancer syndromes have become better under-
stood, but surprisingly many patients overestimate their
risk for cancer and experience anxiety of developing the
disease. Questions concerning risk perceptions in individ-
uals and families and questions about the effect of genetic
counseling on risk comprehension are therefore of partic-
ular relevance [6].
The accuracy of risk estimations varies between studies
[7]. Some reports state that only approximately 25% of
patients have accurate risk perception while 50% of
patients tend to overestimate their risk for cancer [8].
Another study indicated that 50% of the non-affected
patients were accurate in risk perception at baseline before
genetic counseling and the remaining 50% was divided
into equal proportions of underestimations and overesti-
mations [9]. As many as 67% of participants in another
study reported an accurate risk, while among those with
inaccurate risk perceptions equal number of respondents
over or underestimated their risk for cancer [10]. In a Nor-
wegian study 41% of the participants believed that they
had the same or lower risk of developing cancer than their
peers of same age and gender [11].
Oncogenetic counseling was established at the Karolinska
University Hospital in 1990 in order to offer cancer risk
estimates and preventive programs to patients. We have
found no previous study that prospectively examines in
detail various aspects of risk perception and also associate
risk perception to cancer anxiety. The present study was
conducted (1) to evaluate oncogenetic counseling and (2)
to learn from patient experiences in order (3) to improve
the quality of genetic counseling. Risk estimates and anx-
iety about cancer in unaffected and affected individuals
from this study are the focus of this article.Hereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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The following topics were addressed: (1) How do unaf-
fected patients (individuals with no previous cancer diag-
nosis) estimate their own, their sibling's/children's and
the general population's risk of cancer before genetic
counseling, immediately after, and one year after com-
pleted genetic investigations as compared to the risk esti-
mated by an oncogenetic physician?, (2) How do
unaffected patients perceive their own risk compared to
the risk for the general population?, (3) Is there a differ-
ence in risk perception among unaffected individuals if
they would hypothetically participate in a preventive pro-
grams compared to no preventive programs?, (4) Are
there differences in cancer anxiety about developing can-
cer before and after genetic counseling?, (5) Is there a cor-
relation between perceived risk and anxiety about cancer?,
(6) How do affected patients (individuals with a cancer
diagnosis) estimate their siblings/children's risk and the
general population's risk for cancer before, after genetic
counseling and one year after completed genetic investiga-
tions?, (7) Are there differences in cancer anxiety about
developing cancer again before and after genetic coun-
seling?
Materials and methods
The oncogenetic procedure at the Karolinska University 
Hospital
Patients were referred to oncogenetic counseling at the
Karolinska University Hospital based on the basis of fam-
ily history of breast-, ovarian-, colorectal-, endometrial or
gastric cancer either on their own initiative or by their gen-
eral practitioners. During the first consultation an oncoge-
netic nurse informed the patients about the counseling
procedures and established a family pedigree in collabo-
ration with the patient. Prior to the meeting with a clinical
geneticist, cancer diagnoses in the family were confirmed
through medical records and/or death certificates. The
genetic counseling process included a review of: (1) the
family history of cancer, (2) the cancer risk estimation, (3)
the possibility of genetic testing and, (4) the available sur-
veillance programs. At the clinic counselors followed rou-
tines in an effort to guarantee that every patient received
counseling with the same quality. All patients received a
written summary after counseling.
Participants
Only patients with no previous genetic consultation in the
family were eligible to participate in the study. Persons
who had previously been informed about or done pre-
symptomatic testing were not included in this study. A
total of 310 patients who were referred to the Department
of Oncogenetic at the Karolinska University Hospital dur-
ing the course of one year and they were invited to partic-
ipate in a questionnaire study. Questionnaire data was
collected during a study period of three years. All partici-
pants had good Swedish comprehension. Of the 310
invited patients, 254 (82%) showed interest in genetic
investigations while no contact was obtained from 56
(18%) of the patients after referral. None of the partici-
pants were given results of genetic testing during the study
period.
The individual risk of developing cancer (the objective
risk) was estimated for every patient by a geneticist (AL).
The mean risk for cancer in each risk group can be roughly
estimated as the mean value of both breast cancer and
colon cancer risks, because these cancer types are the most
prevalent ones. Thus, the unaffected patients were catego-
rized into four risk groups: same as the general population
511% risk, low 1223%, moderate 2445% and high risk
>45%. The number of unaffected patients was too small
to be analyzed in subsets according to cancer diagnoses.
Affected patients were analyzed as one group because they
were considered to have risk for recurrence, for developing
metastatic disease and risk for developing another pri-
mary cancer.
Questionnaires
The questionnaires were jointly designed by a geneticist
(AL), a psychologist (YB), a nurse (UP) and a bachelor of
public health (GL). The questionnaires were tested on
four patients and found feasible for the study. No formal
reliability testing or validation was performed.
The patients were given separate questionnaires depend-
ing on whether or not they were previously diagnosed
with cancer, i.e., "affected" or "unaffected". The type of
cancer in question was the cancer type the individual had
a family history of. The risk in this context means lifetime
risk.
Questionnaires 1 (before consultation) and 2 (after con-
sultation) included five questions about risk perception
and anxiety that unaffected patients experience about
developing cancer. The first question concerned how
patients estimate their risk of cancer compared with the
risk for anyone in the general population. The patients
were asked to answer the questions of risks according the
type of cancer diagnosis in the family. The respondents
were included only if the patients gave estimations for the
type of cancer which existed in the family. Responses were
given on a five point scale from "Much lower" to "Much
higher". The following items elicited patients' estimation
of their own, siblings/children's and general population's
risk of cancer on a visual analogue scale with the end
points "No risk" to "100% risk". The last question con-
cerned anxiety about developing cancer scored on a scale
"Not at all" to "Very much". In questionnaire 3 (one year
after genetic investigations) unaffected patients estimated
their risk of developing cancer compared to the risk for
anyone in the general population. They estimated theirHereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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own, their siblings/children's and the general populations
hypothetical risk of developing cancer depending on
whether they hypothetically would or would not partici-
pate in preventive programs. Question concerning anxiety
about developing cancer was the same as in questionnaire
1 and 2.
In the questionnaire designed for affected patients, the
question about their own perceived risk of developing
cancer did not exist, but otherwise risk perception ques-
tions were the same as for unaffected individuals in ques-
tionnaire 1 and 2. A question about the anxiety about
developing cancer was formulated as anxiety about devel-
oping cancer again. In questionnaire 3, affected patients
estimated the hypothetical risk to their sibling's/children's
and the general population based on whether or not they
hypothetically would participate in preventive programs.
Evaluation of objective risk
The empirical cancer risk in the family, based on family
history, and personal risk for each patient were assessed
by a geneticist (AL). Risk was defined in four categories;
"The same risk as population", "Low risk", "and Moderate
risk" and "High risk". This assessment was made after the
patients met with one of the counselors at the department
of clinical genetics. For breast cancer empirical risk esti-
mations Claus model were used as guideline. For colon
cancer empirical risk estimations were based on interna-
tional publications [12-19].
Procedure
The questionnaires were completed at three points of
assessment: immediately before genetic counseling, one
week after initial genetic counseling and one year after
completion of genetic investigations. The participants
were sent a questionnaire with information about the
study immediately before the first contact and they
returned the questionnaire at the first counseling appoint-
ment. The second questionnaire was sent together with a
prepaid return envelope to participants one week after the
visit. The third and final questionnaire was sent with a
prepaid return envelope to the participants one year after
completion of genetic counseling. The participants who
did not return the questionnaire received three remain-
ders encouraging them to continue in the study.
Ethical Aspects
The study was performed in accordance with Swedish law
(2003:460) and approved by the local Ethics Committee,
D:nr 2005/566-31/1.
Statistical analysis
Data analyses were performed with the Statistical Package
for the Social Sciences (SPSS) or Statistica 8 program.
Descriptive statistics were generated to arrange the partic-
ipants by age, gender and presence of cancer and risk per-
ception.
Student's t-test (paired and unpaired) and ANOVA facto-
rial designs were used to analyze the differences between
measuring time points and group differences. Spearman's
rho test was used to test the correlation between the risk
perceptions.
Results
Characteristics of participants
A total of 215 patients (85% of eligible patients) returned
at least one questionnaire and were included in the study
(Figure 1). A total of 213 (99% of included patients)
returned the first questionnaire and 164 (76% of included
patients) returned the second questionnaire. The last
questionnaire generated 145 respondents (67%).
Gender and age were used as socio-demographic variables
in the present analyses. There were no statistically signifi-
cant differences in gender, age or medical characteristics
between respondents and non-respondents. The mean
age among non-respondents was 46 (SD = 10.2) and
among respondents 45 (SD = 10.5) at initial contact.
Eighteen percent (n = 7) of non-respondents and 11% (n
Study material Figure 1
Study material. Flow chart illustrates the included and 
excluded patients and the number of respondents in each 
questionnaire.
Invited to the study 
310
No contact 
56
Contact with 
oncogenetic clinic 
254
Refused
participation
39
Included in the study 
215
55 cancer affected and
160 non-affected 
1
st questionnaire  2
nd questionnaire  3
rd questionnaire 
213 respondents 164 respondents  145 respondentsHereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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= 23) of respondents were male. Eighteen percent (n = 7)
of non-respondents were affected; the corresponding fig-
ure for respondents was 26% (n = 55) (p = 0.321).
Affected participants were statistically significantly older
(mean age 54, n = 55) than unaffected (mean age 42, n =
160) [df (1, 213), t = -6.384, p < 0.001]. A total of 47
(25%) female participants were affected, the correspond-
ing figure for men was 8 (35%).
A total of 93 (43%) participants were referred to oncoge-
netic counseling by their own initiative, 110 (51%) by
general practitioners, 14 (7%) by a relative and 9 (4%) by
"somebody else". The participants could choose more
than one response alternative to this item and 12 patients
answered that they participated in counseling both on
their own initiative and on the request of a relative.
A total of 156 patients (60%) had no previous history of
cancer and were categorized as "unaffected" The unaf-
fected participants were referred to genetic counseling due
to a family history of breast- (n = 104), ovarian- (n = 5),
colorectal- (n = 43) endometrial (n = 1) or gastric- (n = 3)
cancer. Information about cancer type and objective risk
was missing in four unaffected participants because they
returned the first questionnaire partly completed and
never attended genetic counseling. However, responses
from these four participants were used in some of the
analysis.
The affected participants were referred to oncogenetic
counseling based on a family history of breast- (n = 22)
ovarian- (n = 9), colon- (n = 15) and endometrial cancer
(n = 1). For 8 patients the information about cancer type
is missing because these participants only returned the
first questionnaire partly filled and never attended genetic
counseling. These 8 responses were used in some of the
analyses.
Risk Perception of non affected participants
Own Risk Perception
Whether the patients were referred to oncogenetic coun-
selling on their own initiative (n = 61) or on general prac-
titioners (n = 62) did not appear to influence their own
risk perception (mean risk estimation 61.9% versus
59.7%, p = 0.567) nor risk perception for children/sib-
lings (50.6% versus 45.8%, p = 0.299) or risk estimates for
general population (29.6% versus 28.9%, p = 0.841).
The type of cancer history in the family did not appear to
influence the risk perception. The difference in risk per-
ception between the two most prominent cancer types
was not statistically significant before genetic counseling;
mean risk perception in breast cancer families was 62.5%
(n = 93) and in colon cancer families 56.1% (n = 34), (p
= 0.132). After genetic counseling the mean risk percep-
tion in colon cancer families was 45.1% (n = 29) and
48.0% in breast cancer families (n = 69), (p = 0.593).
There were no statistically significant differences in risk
perception for children either between individuals with
breast cancer (47.5%, n = 101) or colon cancer (51.4%, n
= 43), (p = 0.379) in the family.
As the number of individuals in each cancer type group
was small, the individual responses independent on can-
cer diagnosis were combined in order to increase statisti-
cal power.
Before genetic counseling all of the risk groups subjec-
tively estimated the risk as higher than the objective risk.
Subjective estimations in all participant groups ranged
between 55% and 78% (Figure 2). The participants with a
similar risk as the population overestimated their risk the
most. Individuals with moderate and high risk for cancer
were more accurate in subjective risk estimations.
A total of 91% (n = 82) of unaffected participants altered
their risk perception after genetic counseling (Figure 3).
Of them, 68% (n = 61) showed a decrease in risk percep-
tion while 23% (n = 21) reported increased risk percep-
tion. Nine percent (n = 8) had the same risk perception at
both points of assessment.
The difference in subjective risk perception before and
directly after genetic counseling was statistically signifi-
cant [df = (1, 90), t = 4.73, p < 0.001]. Difference in risk
perception for children was also statistically significant [df
= (1, 78), t = 5.05, p < 0.001], as well as difference in risk
perception for the population [df = (1, 82), t = 3.50, p =<
0.001]. The perception of one's own cancer risk was more
accurate directly after genetic counseling in the groups
with the same risk as the general population and low risk
(Figure 2). Moderate risk individuals did not show any
change in risk perception after genetic counseling. In the
group with the same risk as the general population, risk
perception was reduced from 69% to 39%, although still
almost four times higher compared to their objective risk.
Low risk participants reduced their risk perception from
64% to 46%, still more than two times higher than their
objective risk. Individuals in the moderate risk group
overestimated their risk by 20% compared to their objec-
tive risk.
One year after genetic investigations, the unaffected indi-
viduals were asked about their perceived risk contingent
upon participation in prophylactic interventions such as
check-ups (i.e. mammography and colonoscopy) or pre-
ventive surgery. The hypothetical risk perception was
lower if the participants would take part into preventive
programs than without such interventions (37% versusHereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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56%) [df = (1, 80), t = 7.57, p < 0.001]. The moderate and
high-risk individuals reported the largest difference in risk
estimation depending on whether or not they considered
attending preventive programs (moderate risk individuals
without control 62% versus with check-ups 39% and high
risk individuals without check-ups 74% versus with con-
trol 31%.
There were no statistically significant differences in mean
risk estimation between individuals with breast or colon
cancer risks if they hypothetically would participate in
preventive programs.
Risk perception for sibling/children and general population
Risk perception for children was independent of the type
of cancer in the family. Individuals in breast cancer fami-
lies had a mean risk estimation for children/siblings of
48.9% before genetic counseling and colon cancer fami-
lies had 48.9% (p = 0.761). After genetic counseling the
risk estimation were 34.9% versus 41.0% (p = 0.534).
Subsequently, results from the total sample have been
analyzed together.
Perceived risk for siblings/children was significantly lower
than personal risk estimation [df = (1, 119, t = 5.89, p <
0.001], but was also overestimated with a mean estima-
tion of 48.1% before and 33.9% after genetic counseling,
statistical significant over time (p < 0.001). In the groups
with the same risk as the general population and low risk,
the participants showed biggest differences in risk percep-
tion before and after genetic counseling (Figure 4). Risk
perception for the general population was also overesti-
mated, but lower than the risk perceived for children [df =
(1, 146) t = 8.00, p < 0.001] (Figure 5).
Own subjective risk perception Figure 2
Own subjective risk perception. Own subjective risk perception in unaffected patients before and after genetic counseling 
illustrated separately stratified according to objective risk estimated by the clinical geneticist (population, low, moderate and 
high risk). The mean, standard, and 95% CI and outliers are shown.
Box Plot of multiple variables grouped by  10:1. dr risk
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One year after genetic investigations the unaffected indi-
viduals were asked about their children's/siblings and
general population's hypothetical risk if they would not
participate in preventive programs. Risk perception was
46.9% for children and for the general population 29.0%.
The cancer type or the objective risk did not have influ-
ence in risk perception.
Perceived risk of developing cancer compared to the risk 
for anyone in the general population
After genetic counseling, more participants (55%) in the
population risk group reported that they had an equal risk
of developing cancer compared to anyone in the general
population compared to before genetic counseling
(4.3%) (Table 1) A total of 96% of participants in the pop-
ulation risk group perceived the risk as higher than or as
much higher as the risk for anyone in the general popula-
tion. After genetic counseling however, this proportion
decreased to 45%. This difference was statistically signifi-
cant [df = (1, 20), t = -3.23, p = 0.005]. None of the other
risk groups showed such a clear change in risk perception.
The correlation between risk perception for anyone in the
general population and for personal risk was statistically
significant [r = 0.450, p < 0.001] when measured on the
first occasion and also after genetic counseling [r = 0.462,
p < 0.001]. One year after genetic investigations the corre-
lation between risk perception for themselves and for the
general population was also statistically significant when
asking hypothetically the patients if they would partici-
pate in a preventive program [r = 0.380, p < 0.001] or if
they would not participate [r = 0.460, p < 0.001].
Experienced anxiety about developing cancer
Experienced anxiety about developing cancer according to
the risk group and point of time for assessment is dis-
Change in risk perception among unaffected participants Figure 3
Change in risk perception among unaffected participants. Increases and decreases in perceived risk after genetic coun-
seling for all unaffected patients who responded to the first and second questionnaires (n = 90). Up-going arrow shows 
increase in risk perception after genetic counseling and down-going arrow show decrease in risk perception after genetic coun-
seling. When two dots are presented but no arrow, it means that the risk perception has not changed. Every arrow represents 
one patient.
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played in Figure 6. The degree of experienced anxiety
about developing cancer in the unaffected subjects was
lower after genetic counseling compared to the baseline in
all other groups [df = (1, 105), t = 5.79, p < 0.0001], except
in high risk individuals. The difference in anxiety immedi-
ately after genetic counseling and one year after was not
statistically significant.
Correlation between experienced anxiety about 
developing cancer and estimated risk for cancer
The correlation between perceived risk and anxiety about
developing cancer was statistically significant before
genetic counseling [n = 140, r = 0.412, p < 0.001], after
genetic counseling [n = 101, r = 0.416, p < 0.001] and one
year after genetic investigations among unaffected
patients. One year after genetic investigations, the ques-
tion was presented depending on what the patients
thought the risk would be if they would participate in pre-
ventive programs [n = 81, r = 0.346, p = 0.002] and if they
would not participate in preventive programs [n = 81, r =
0.414, p < 0.001].
Risk perception of affected participants
Whether or not the subjects were referred to oncogenetic
counseling on their own initiative or on general practi-
tioners initiative did not influence risk perception for chil-
dren (mean risk estimation 47.7% versus 58.7%, p =
0.180 nor the risk perception for the general population
(mean risk estimation 30.4% versus 31.9%, p = 0.820).
The affected subjects did not estimate their own risk due
to previous cancer history.
Risk perception for children before genetic counseling
between the two most prominent cancer types were not
Risk perception form siblings/children Figure 4
Risk perception form siblings/children. Risk perception for sibling and children before and after genetic counseling in unaf-
fected patients illustrated separately stratified according to objective risk estimated by the clinical geneticist (population, low, 
moderate and high risk). The mean, standard error, 95% CI and outliers are shown.
Box Plot of multiple variables grouped by  10:1. dr risk
Sheet1 in nyaste version_090509.stw 28v*215c
Mean; Box: Mean±SE; Whisker: Mean±0.95 Conf. Interval
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statistically significant, 46.9% in breast cancer families
and 68.3% in colon cancer families (p = 0.066). Thus, the
results from all affected individuals independent the can-
cer type are analyzed together.
Risk perception for siblings and children and for the 
general population
The affected participants overestimated their children's
risk as well as the risk for anyone in the general popula-
tion. The difference in risk perception for children/sib-
lings was statistically significant before (mean 57.1%)
versus immediately after genetic counseling (mean
48.2%) [df = (1, 22) t = 2.04 p = 0.054]. Risk perception
remained about the same one year after genetic investiga-
tions [df = (1, 16), t = -1.04, p = 0.313].
Differences in risk perception for the general population
were also statistically significant before (mean 37.2%)
versus after genetic counseling (mean 29.5%) [df = (1,
22), t = 2.54, p = 0.019]. There was no difference in risk
perception between the second and third assessment for
the general population.
Anxiety about developing cancer again
Anxiety about developing cancer again among affected
participants continued to be high throughout this investi-
gation (Figure 6). Anxiety was estimated on a scale from
very much (7) to not at all (1). The mean anxiety was 5.06
(SD = 1.72) before genetic counseling, 5.03 (SD = 1.69)
after and 5.03 (SD = 1.54) one year after genetic investiga-
tions. There was no statistically significant difference
between any of the assessment points.
Risk perception for the general population Figure 5
Risk perception for the general population. Risk perception for the general population before and after genetic coun-
seling in unaffected patients illustrated separately stratified according to objective risk estimated by the clinical geneticist (pop-
ulation, low, moderate and high risk). The mean, standard error, 95% CI and outliers are shown.
Box Plot of multiple variables grouped by  10:1. dr risk
Sheet1 in nyaste version_090509.stw 28v*215c
Mean; Box: Mean±SE; Whisker: Mean±0.95 Conf. Interval
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Discussion
The current study reveals the personal risk perception
related to the objective cancer risk and associates the per-
sonal risk perception to the risk for children and the gen-
eral population. The results indicate that before genetic
counseling subjective risk was overestimated by the
majority of participants, especially among those with low
objective risk. Risk perception, however, were more accu-
rate after genetic counseling among the low risk subjects
that had been most worried. The perceived risk for sib-
lings, children and the general population was overesti-
mated by both affected and unaffected patients, but was
also more accurately assessed after genetic counseling.
Participating in preventive programs was considered to
result in decreased risk. Cancer anxiety in unaffected
patients decreased after genetic counseling, but was still
associated with perceived risk throughout the year follow-
ing genetic investigation. Cancer anxiety in affected
patients did not appear to be influenced by genetic coun-
seling.
An accurate perception of one's own risk and level of anx-
iety are important. In the literature, data indicate that
increasing perception or personal vulnerability, such as
greater anxiety, is associated with a higher use of health
care actions [20]. Patients who underestimate their risk for
cancer may not give sufficient attention to preventive pro-
cedures and overestimation of risk might lead to anxiety
and unnecessary use of medical services [21]. Participants
with a diagnosis of cancer reported higher levels of anxi-
Table 1: Risk perception compared to anyone in general population
Before Counseling % After Counseling % 1 year after Surveillance program 
%
1 year after No surveillance 
program %
Population n = 23 n = 22 n = 11 n = 11
Much higher (=5) 17.4% 13.6% - -
Higher (=4) 78.3% 31.8% 18.2% 63.6%
Equal (=3) 4.3% 54.6% 36.4% 27.3%
Less (=2) - - 45.4% -
Much less (=1) - - - 9.1%
Mean value at scale 15 (SD) 4.13 (0.33) 4.08 (0.66) 2.8 (0.64) 3.4 (0.72)
Low n = 51 n = 47 n = 37 n = 39
Much higher (=5) 21.6% 17% 5.5% 12.8%
Higher (=4) 64.7% 70.2% 40.5% 76.9%
Equal (=3) 13.7% 12.8% 27% 7.7%
Less (=2) - - 27% 2.6%
Much less (=1) - - - -
Mean value at scale 15 (SD) 4.1 (0.41) 4.05 (0.35) 3.22 (0.85) 4.00 (0.27)
Moderate n = 41 n = 38 n = 35 n = 35
Much higher (=5) 26.8% 34.3% 2.9% 31.4%
Higher (=4) 63.4% 60.5% 45.7% 62.9%
Equal (=3) 7.3% 2.6% 20% 5.7%
Less (=2) 2.5% - 25.7% -
Much less (=1) - 2.6% 5.7% -
Mean value at scale 15 (SD) 4.15 (0.49) 4.23 (0.56) 3.17 (0.9) 4.27 (0.44)
High n = 5 n = 5 n = 5 n = 5
Much higher (=5) 60% 11.1% - 60%
Higher (=4) 40% 66.7% 40% 20%
Equal (=3) - 22.2% 20% 20%
Less (=2) - - 40%% -
Much less (=1) - - - -
Mean value at scale 15 (SD) 4.6 (0.48) 4.17 (0.28) 3.00 (0.8) 4.4 (0.72)
Risk for developing cancer compared to risk for anyone in general population in different risk groups on a scale from "much higher" to "much less" 
assessed by unaffected participants. The values are the proportion of patients in each risk category, according to perceived risk compared to the 
risk for anyone in the general population.Hereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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ety, demonstrating quantitatively that cancer diagnosis
affects general well-being. This must be taken into consid-
eration when counseling affected individuals [22].
Participants perceived their own risk as being higher than
the risk for anyone in the general population, results
which are in concordance with a previous Swedish study
[22]. Even those with an objective risk similar to the gen-
eral population overestimated their risk. This finding is
not surprising considering that they attended the clinic
due to a subjective perception of increased risk for cancer
or that their general practitioners revealed concern about
the risk. The risk perceptions were, however, more accu-
rate in these groups after genetic counseling, although still
higher than the actual estimation determined by the
genetic counselor.
In 1993 a pilot study of risk perception indicated that only
11% of women in a family affected with breast cancer
were able to identify the accurate risk for women in the
general population. Less than half were able to identify
their own lifetime risk within 50% range of the coun-
selor's estimation [23]. A follow-up study reported that
33% of participants had the correct risk estimation for the
general population after genetic counseling and 41% esti-
mated their own risk accurately [24]. In a Swedish study
of women who were considering a prophylactic mastec-
tomy due to a hereditary increased risk for breast cancer
but with no previous cancer history, 25% overestimated
their risk for cancer by more than 20% although 28% of
women underestimated their risk by more than 20% [22].
In the present study, a radical overestimation of the risk
was shown in unaffected individuals with low or similar
Cancer anxiety Figure 6
Cancer anxiety. Anxiety in unaffected an affected patients before, after genetic counseling and 1 year after genetic investiga-
tions is illustrated. Unaffected patients are stratified according to objective risk estimated by the clinical geneticist (population, 
low, moderate and high risk). The mean and standard errors are shown.
time point*subjective risk; LS Means
Current effect: F(8, 415)=1.2631, p=.26113
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risk as the general population. This finding is in concord-
ance with a German study showing that moderate and low
risk individuals made the most marked overestimation
[25]. This phenomenon was also reported in a Swedish
study of risk perception in individuals at risk for colon
cancer who participated in a surveillance program.
Among those having slightly increased risk (120% life-
time risk), 60% overestimated their risk [26]. Individuals
with real increased risk were more accurate in the current
study, a similar phenomenon was shown in the German
study as well [25]. The previous Swedish study also unex-
pectedly reported that after genetic counseling the major-
ity of the mutation carriers with an 80% objective lifetime
risk underestimated their risk. 61% of subjects estimated
their risk as being 40% or less and 36% estimated a 120%
risk. Only half of the patients having a 40% lifetime risk
estimated that risk correctly [26]. Liljegren et al. reported
that the risk estimations varied widely, but suggested that
the most important task in genetic counseling is to ensure
that those with increased risk attend surveillance pro-
grams and do not suffer from anxiety or depression.
The finding in this study of more accurate risk estimation
after genetic counseling is supported by a number of stud-
ies [7,27]. However the long-term effect is unclear. In one
Swedish study the proportion of accurate risk estimators
increased after consultation but decreased again one year
after genetic investigations. The proportion of under and
overestimators was halved after genetic counseling, but
both increased one year after consultation to the level
before genetic counseling [28]. In the present study the
risk perception did not appear to change from the assess-
ment point after genetic counseling to the one-year assess-
ment. Recall based on cognitive functioning is probably
one reason for more accurate risk estimates directly after
counseling, whereas long term risk perception is influ-
enced by emotions and thus involves interpretation.
In the present study the unaffected subjects considered
their risk to be lower if they considered participation in a
preventive program as compared to not participating in
such a program. The largest difference in risk perception
considering participation in preventive programs was
found among moderate and high risk individuals. These
participants reported the risk as being 40% lower with a
surveillance program. The importance of preventive pro-
grams is thus understood and the results demonstrate the
importance of giving recommendations and supporting
patients to participate in check-up procedures. The most
of the participants were not included in preventive pro-
grams during the time of the current study. A study about
predictive testing for HNPCC post-test delineated that
none of the non-carriers and all of the mutation carriers
adhered to the recommendations [29]. Many other stud-
ies have also shown that knowledge about the benefit of
surveillance programs in reducing the risk of cancer is
beneficial among patients with increased risk for cancer
and that prophylactic measures are appreciated and
believed to be effective [30,31].
Experienced anxiety about cancer in the unaffected
patients reduced significantly in all risk groups after
genetic counseling in accordance with previous studies
[11,32]. The anxiety about cancer continued to decrease
slightly also one year after genetic investigations except in
low risk patients where the level of anxiety remained
approximately the same as at the assessment point after
genetic counseling. In all risk groups the proportion of
individuals with high levels of cancer anxiety tended to
decrease immediately after genetic counseling with a fur-
ther decline one year afterwards. A similar tendency was
reported by Bish et al [33]; anxiety about developing can-
cer and perception of the likelihood of being a mutation
carrier decreased significantly after genetic counseling.
However, the same study reported that general psycholog-
ical distress did not change over the course of follow-ups
before and after genetic counseling. Hopwood et al
describes that after genetic counseling, women with over-
or underestimated risk perception had significantly higher
general health distress levels than women with accurate
risk-knowledge. As their main concern, the women
reported not only risk of breast cancer but even themes of
loss, unresolved grief and problems within relationships
[34]. Thus a number of factors might affect general dis-
tress. General distress was, however, not examined in the
present study.
Affected patients had a tendency to overestimate the gen-
eral population risk for cancer. The same was found in a
study of breast cancer concerns in women attending a
genetic counseling clinic at a comprehensive cancer
center. Affected and unaffected individuals perceived that
the women who had already developed cancer are less
likely in risk to develop cancer again. When asking the
affected patients to recall what they thought their risk was
before cancer onset, they estimated the risk of developing
breast cancer from 0 to 100% with a mean of 31%. The
unaffected women estimated their risk to be approxi-
mately 15% with a range 5100%. The lowest risks were
reported by the youngest and by women who have under-
gone bilateral mastectomy. Many women thought that
their risk was confined to the next 10 years, being 33%
(mean) for affected with 075% range and for unaffected
56% (mean) varying between 0 and 100% [35].
Women with a family history of cancer and overestima-
tion of risk have been shown to report significantly higher
breast cancer specific distress [36]. In the present study the
affected individuals showed more concerns about cancer
and they had higher perceptions of risk for other cancersHereditary Cancer in Clinical Practice 2009, 7:15 http://www.hccpjournal.com/content/7/1/15
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than non-affected. This is natural because affected indi-
viduals have risk for developing recurrence and metastasis
disease and also risk for another primary cancer. This indi-
cates the need for more sensitive counseling to affected
individuals [34].
The present study has some limitations. The question-
naires were developed by the researchers and not formally
validated or reliably tested. Cancer anxiety was assessed
by one question which could be considered imprecise.
However, it showed changes over time, giving at least an
indication that anxiety decreased after genetic counseling.
In addition, associations between personal risk estima-
tion and cancer anxiety were revealed. Perceived risk (sub-
jective risk) was assessed by a VAS scale where risk was
stated as a point estimate. Objective risk was based on the
family pedigree (cancer history) and stated in four catego-
ries. This difference might have impacted the findings as
small changes in perceived risk were recorded and com-
pared to the wide categories of objective risk.
According to a review on approaches to communicating
health risks, numerical information regarding the proba-
bility that a health problem occurs is difficult to under-
stand. The patients found risk information through
numerical probabilities such as absolute numbers, rela-
tive risks, ratio and frequency of events or proportions as
too scientific. This problem has been underestimated by
clinicians in health care. An alternative way to inform
patients about the risks is to give verbal descriptions like
"an unlikely event" or "risk higher than average" [37].
This way of conveying the risks could be easier because the
patients tend to reformulate the risk information accord-
ing to personal and family experiences of cancer and relate
the risk to lifestyle. They reconstruct the risk according to
what they believe about inheritance and what experience
of cancer the family has. It might be an attempt to get back
control of their destiny or to understand how cancer is
inherited via generations or that the patients try to con-
nect the environment with genetics [38]. It has been
shown that there is a connection between observed
knowledge of hereditary cancer and understanding of per-
sonal cancer risk. Thus, the counseling strategies exploit
the fact that knowledge derived from experience often
takes precedence over an objective risk estimate. Subse-
quently, communication regarding patient experiences
may enhance risk perception [39,8].
Conclusion
The participant's accuracy in risk perception was poor,
especially in low risk individuals before genetic coun-
seling. There was a general trend towards more accurate
estimation in all risk groups after genetic counseling. The
importance of preventive programs was well understood.
Cancer anxiety was prevalent and associated with risk per-
ception, but decreased after genetic counseling.
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